MMV's pipeline of antimalarial drugs

Download the MMV-supported projects slide and the global portfolio of antimalarial medicines slide.

Detailed information is available for translational, development and access projects (click on the boxes below).

MMV's pipeline of antimalarial drugs

Access
View project
Artemether-lumefantrine dispersible
Novartis
Uncomplicated malaria
Approved
View project
Pyronaridine-artesunate granules
Shin Poong
Uncomplicated malaria
Approved
View project
Tafenoquine paediatric
GSK
Prevention of relapse
Approved
View project
Dihydroartemisinin-piperaquine
Alfasigma
Uncomplicated malaria
Approved
View project
Artesunate- amodiaquine
Sanofi
Uncomplicated malaria
Approved
View project
Pyronaridine- artesunate
Shin Poong
Uncomplicated malaria
Approved
View project
Artesunate- mefloquine
Cipla
Uncomplicated malaria
Approved
View project
Artesunate for injection
Ipca
Severe malaria
Approved
View project
Artesunate for injection
Fosun Pharma
Severe malaria
Approved
View project
Sulfadoxine- pyrimethamine+ amodiaquine dispersible
Fosun Pharma
Chemoprevention for children
Approved
View project
Sulfadoxine- pyrimethamine+ amodiaquine dispersible
S Kant
Chemoprevention for children
Approved
View project
Artesunate rectal capsules
Cipla
Pre-referral intervention
Approved
View project
Sulfadoxine-pyrimethamine
Universal Corporation
Prevention for pregnant women and infants
Approved
View project
Artesunate rectal capsules
Strides Pharma
Pre-referral intervention
Approved
View project
Tafenoquine
GSK
Prevention of relapse
Approved